Transforming the Future of Facial Diagnostics
Combining photonic technology and explainable AI to enable earlier, more accurate detection of facial diseases.
Who We Are
Cellunoma is a medical technology company focused on redefining how facial diseases are detected, analysed, and monitored in clinical environments.
We develop intelligent diagnostic solutions that move healthcare beyond subjective visual inspection toward objective, data-driven insights—helping clinicians deliver faster, more accurate care.
Our Mission
Our mission is to make early detection of facial cancers and other facial conditions practical, consistent, and accessible in routine clinical settings.
We aim to empower clinicians with reliable tools that support better decision-making and improve patient outcomes.
Our Approach
At Cellunoma, we combine advanced photonic imaging with explainable artificial intelligence to create solutions that are both powerful and clinically practical.
Our approach focuses on:
Designed for Clinical Environments
Our technology is built with real-world clinical use in mind:
● Ergonomic and sanitisation-ready design
● Guided workflows for consistent results
● Configurable integration with clinical systems
● Secure data handling with encryption and role-based access
This ensures smooth adoption without disrupting existing processes.
Empowering Clinicians & Patients
Beyond technology, Cellunoma focuses on improving communication and engagement between clinicians and patients.
Our solutions provide clear visual reports and interpretable findings, helping clinicians explain risks and next steps more effectively—leading to better understanding, trust, and follow-up adherence.
Our Vision
We envision a future where facial disease detection is:
● Continuous instead of episodic
● Objective instead of subjective
● Proactive instead of reactive
Cellunoma is working to expand its technology across primary care, dermatology, oncology, and telemedicine—bringing advanced diagnostics to more people worldwide.